← FDA DRUG APPROVALS

FDA NDA · NDA018634

BETADINE

povidone-iodine

Sponsor: ALCON PHARMS LTD

APPLICATION
NDA018634
TYPE
NDA
ORIGINAL APPROVAL
1986-12-17
LATEST ACTION
2013-08-26
ROUTE
OPHTHALMIC
DOSAGE FORM
SOLUTION/DROPS
MARKETING STATUS
Prescription

Products

BETADINE · ReferencePrescription
POVIDONE-IODINE 5% · SOLUTION/DROPS · OPHTHALMIC

Approval history

2013-08-26Manufacturing (CMC) · Supplement 13 · standardAP
2003-05-21Labeling · Supplement 7 · standardLetterAP
2000-02-07Manufacturing (CMC) · Supplement 6 · standardAP
1991-12-30Labeling · Supplement 4AP
1991-12-30Manufacturing (CMC) · Supplement 2 · standardAP
1989-10-27Manufacturing (CMC) · Supplement 1 · standardAP
1986-12-17Type 3 - New Dosage Form · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →